ABSTRACT The anti-vascular therapy has been extensively studied for high performance tumor therapy by suppressing the tumor angiogenesis or cutting off the existing tumor vasculature. We have previously reported a novel anti-tumor treatment technique using radiofrequency (RF)-assisted gadofullerene nanocrystals (GFNCs) to selectively disrupt the tumor vasculature. In this work, we further revealed the changes on morphology and functionality of the tumor vasculature during the high-performance RF-assisted GFNCs treatment in vivo. Here, a clearly evident mechanism of this technique in tumor vascular disruption was elucidated. Based on the H22 tumor bearing mice with dorsal skin flap chamber (DSFC) model and the dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) technique, it was revealed that the GFNCs would selectively inset in the gaps of tumor vasculature due to the innately incomplete structures and unique microenvironment of tumor vasculature, and they damaged the surrounding endothelia cells excited by the RF to induce a phase transition accompanying with size expansion. Soon afterwards, the blood flow of the tumor blood vessels was permanently shut off, causing the entire tumor vascular network to collapse within 24 h after the treatment. The RF-assistant GFNCs technique was proved to aim at the tumor vasculature precisely, and was harmless to the normal vasculature. The current studies provide a rational explanation on the high efficiency anticancer activity of the RF-assisted GFNCs treatment, suggesting a novel technique with potent clinical application.
INTRODUCTION
Tumor angiogenesis is the foundation of tumor growth and metastasis, and in average each tumor blood vessel feeds thousands of tumor cells to maintain their rapid reproduction [1] . Compared with the normal vasculature, the tumor blood vessels usually have abnormal morphology [2] , such as incomplete vessel walls, loose cell-cell connections between the tumor endothelial cells, and structurally abnormal basement membrane, etc. [3] [4] [5] [6] [7] . Moreover, the blood flow of tumor vasculature is often sluggish and some blood vessels are not continuously perfused [8, 9] , leading to the observed hyper-permeability and high interstitial fluid pressure in solid tumors [10] [11] [12] [13] . These unique vascular features of tumor blood vessels naturally provide us a chance to selectively destruct them by developing advanced tumor vascular targeting therapeutic techniques. Because these techniques do not need to directly destruct billions of cancer cells, they are obviously much more effective than the traditional methods for tumor therapy [14] . Aiming at the relatively weaker vascular structure of tumors comparative to that of normal organs, scientists invented some vascular disrupting agents (VDAs) that can disrupt the tumor vasculature through depolymerizing the endothelial microtubules or augmenting local cytokine productions [15] [16] [17] [18] [19] [20] . It was revealed that most of the VDAs, such as CA4P, FAA/DMXAA, OXi4503, AVE8062 and ZD6126, indeed efficiently damage the tumor vasculature, but they also show serious cardiotoxicity which largely limits their clinical applications [21] .
Recently, we reported a new technique based on the radiofrequency (RF)-assisted gadofullerene nanocrystals (GFNCs) which exhibited high-efficient antitumor activity and low toxicity to normal tissues, and may overcome the big problems of VDAs [22] . Briefly, the gadofullerene based nanomaterials were modified with hydroxyl groups on the surface of carbon cage to form the water soluble GFNCs [23, 24] . When performing the tumor therapy, the GFNCs solution was intravenously injected to the testing tumor-bearing mice, and partial of the GFNCs particles would reach the tumor blood vessels along with the blood flow and try to penetrate out through the vascular leaks. With the radiation by RF, the tumor vasculature was speculated to be destroyed with the explosive volume expansion of GFNCs in anti-tumor activity but not the magnetocaloric effect [22] . On the contrast, for the vasculature of normal organs, there are no leaks on the blood vessel walls to trap the GFNCs particles, so the phase transition of GFNCs would be harmless. In previous papers, we mainly studied the size expansion mechanism and showed the high efficiency of this technique in tumor therapy. This novel technique showed potential therapeutic advantages for clinical applications, which need to be further investigated.
To unravel the mechanism involved during the tumor vascular disruption, we further made a systematic and detailed investigation on the vascular therapeutic process in this work. Various characterization techniques [25] [26] [27] [28] [29] were adopted to monitor the real-time changes of relevant tumor vasculatures and the tumor necrosis by the RF-assisted GFNCs treatment. For example, the fluorescent microscopy technique combined with a mice tumor vascular dorsal skin flap chamber (DSFC) model [30] was employed to observe the vascular morphological changes during the treatment; the magnetic resonance imaging (MRI) was used to evaluate the blood perfusion and vascular permeability of tumor vasculature [31, 32] ; the dynamic contrast enhanced (DCE) MRI was applied to noninvasively and quantitatively evaluate the vascular function of lesions and the extent of tumor angiogenesis in vivo, which provided valuable physiopathologic information for tumor vascular-disrupting treatments [33, 34] . The results showed that the RF-assisted GFNCs disrupted the tumor vasculature and induced an irreversible collapse of the tumor vascular net, and thereby the blood supply of tumor vessels was sharply cut off, resulting in extensive tumor necrosis.
EXPERIMENTAL SECTION

Materials
All reagents and solvents were obtained commercially and used without further purification. Solid Gd@C 82 (99% purity) was purchased from Xiamen Funano Co. Ltd. (Xiamen, China). The 30% hydrogen peroxide (H 2 O 2 , A.R.) and ethanol (C 2 H 5 OH, A.R.) were purchased from Beijing Chemical Works, China. Fluorescein isothiocyanate (FITC)-dextran (average molecular weight-40,000) and Rhodamine B isothiocyanate-dextran (average molecular weight-70,000) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Gadopentetate dimeglumine injection (Gd-DTPA) (15 mL, 7.04 g) was purchased from Bayer Schering Pharma AG, Germany. Pentobarbital sodium salt was purchased from SigmaAldrich. Isoflurane was purchased from RWD Life Science Co. Ltd. (Shenzhen, China). The DSFC device was purchased from APJ Trading Co. Inc., USA.
Preparation and characterization of the GFNCs
The water-soluble GFNCs were synthesized via a facile solid-liquid reaction as previously reported [35] . The solid Gd@C 82 was directly added to the hydroxyl moieties H 2 O 2 by nucleophilic additions in alkaline conditions. The mixture was vigorously stirred for 40 min at 50°C. The suspension obtained was washed with ethanol three times and then dialyzed overnight in ultrapure water.
The purity of the as-prepared GFNCs (20 µL, 1.0 mg mL −1 ) was verified on the Cosmosil column by high performance liquid chromatography (HPLC, LC10A, Shimadzu, Japan) with an evaporative lightscattering detector (80°C, 3.5 bar of nitrogen pressure, sedex75). The mobile phase was 90% acetonitrile in water with a flow rate of 1.0 mL min −1 . The GFNCs were further characterized using Fourier transform infrared spectroscopy (FTIR, Nicolet iN10TM, Thermo Scientific, USA). The size of the GFNCs in pure water was measured with atomic force microscopy (AFM, Nano Wizard 4 Nano Science, JPK, Germany) and dynamic light scattering (DLS, ZS90, Malvern, UK).
The 300 MHz radiofrequency generator
The RF generator used was the standard equipped 300 MHz resonance frequency generator in a 7T MRI scanner (BioSpec70/20 USR, Bruker, Germany). To conveniently compare experiments in the DSFC model, a home-made 300 MHz radiofrequency generator was included in the commercial MXG Analog Signal Generator (100 kHz -1 GHz, N5181A, Agilent, USA), and a signal amplifier BLAXH 20 (Bruker, Germany) and a self-designed small RF coil were used on the DSFC device. The RF power (1 dBm, 10% duty circle) could easily be monitored by the spectrum analyzer (DSA 815, RI-GOL, China).
Animal models
All animal studies were undertaken in accordance with national and local ethical committee regulations. This study was performed on BALB/c mice for the DCE-MRI and nude mice for the DSFC model (female, 4-5 weeks, weighing 18-20 g), which were both housed in a standard pathogen-free room at the Institute of Process Engineering, Chinese Academy of Sciences. Hepatoma 22 cells (H22) (5×10 6 tumor cells in 100 μL of saline) were injected subcutaneously into the mice in the right rear flank area. The experiments were conducted when the tumors reached a volume of 100 mm 3 5-7 days after the tumor inoculation. The tumors were irradiated in the 300 MHz RF generator for 1.5 h via an intravenous injection of GFNC solution (50 mg kg -1 ) for treatment and using saline as a control.
DSFC model
For the DSFC model, the window chambers were surgically implanted into BALB/c nude mice as previously described with slight modification [36] . The experiments were performed under aseptic conditions in a specific pathogen-free environment.
During the operation, the mice were anesthetized with 2% pentobarbital sodium (100 µL). The entire back of the mouse was disinfected with iodophor, and two symmetrical titanium frames (with diameters of 27 mm) were implanted to sandwich the skin. The skin and the chambers were sutured together with 6.0 nylon around the windows so that as many blood vessels as possible could be located in the center of the window and fixed without influence from the beating of the heart or breathing. One layer of the skin was removed from a circular area approximately 15 mm in diameter, and the remaining layer was covered with a microscope glass slip in diameter of 12 mm, which was incorporated into one of the frames. The exposed skin was then placed surface down in sterile neutral saline. During the surgery, suspended Hepatoma 22 cells (H22) (5×10 7 mL -1 ) were prepared and 10 μL was inoculated in the skin muscle closed to the vessels in the DSFC. Then, the mice with DSFC tumors were given the antibiotic amoxicillin in their drinking water (250 mg per 5 mL of water) and were maintained at 23°C and 50% humidity with free access to food and water and standard 12 h light/dark cycles.
All the images of tumor vasculature and normal vasculature were acquired at 5-7 days after H22 tumor inoculation and DSFC transplantation. The mice bearing DSFC were anaesthetized via isoflurane inhaled through a nose cone and immobilized onto the microscope stage using a custom platform to minimize motion from breathing and circulation for real-time imaging.
Real-time optical imaging of blood vessels in DSFC model
Blood vessels in DSFC models were imaged directly and stably on a custom platform for bright field imaging by the upright optical microscope (OPSTEC, CCD: SONY ICX452AQ) at ×4 objective.
For assessing the morphological change of tumor vasculature under RF-assisted GFNCs treatment, the control cohort of only RF treated ones (RF-control) in tumor vessels was set and the cohort of RF-assisted GFNCs treated ones in normal tissue vessels was also set for morphological change research.
Real-time fluorescence imaging of blood vessels in DSFC model
The intravital fluorescence imaging of vasculature was performed using an upright fluorescence microscope (Nikon ECLIPSE Ni-U, Japan) with a 20× objective. Fluorescein isothiocyanate-dextran (40 kDa, 75 μL of 25 mg mL −1 ) was intravenously injected into the mice to label the blood vessels. The excitation filter of 475 ± 25 nm on the fluorescent tube turntable (NI-FLT6) switch was used for FITC channel.
For assessing the tumor vascular change under RF assisted GFNCs treatment (Treatment), only RF treated group (RF-control) in tumor blood vessels were as control. In addition, the group of RF assisted GFNCs treated normal tissue vasculature was used as other control group for studying the effect of RF-assisted GFNCs treatment on normal vasculature.
Fluorescence imaging of tumor sections
We visualized tumor blood vessels in the treatment group using 2D-fluorescence imaging performed with an upright fluorescence microscope (Nikon ECLIPSE Ni-U, Japan). Rhodamine B isothiocyanate-dextran (70 kDa, 150 μL of 5 mg mL ) was intravenously injected into the mice to label the blood vessels. The tumor was carefully dissected within 10-15 min after Rhodamine B isothiocyanate-dextran injection, immediately immersed in optimum cutting temperature (OCT) compound and frozen at −20°C for 10 min. A series of 50 μm frozen sections from central regions of each tumor were sliced using microtome cryostat (Leica CM1950, Germany) and imaged immediately with a 20×objective. Excitation of rhodamine B was performed with the filter of 575 ± 25 nm on the fluorescent tube turntable (NI-FLT6) switch.
DCE-MRI
The DCE-MRI experiments were performed on a 7T MRI system (BioSpec 70/20 USR, Bruker, Germany). The mice were anaesthetized with a 2% isoflurane-oxygen mixture in an isoflurane induction chamber, as this form of anesthesia provides concentration-dependent rapid general anesthesia and quick recovery after the discontinuation of isoflurane administration [37] . Body temperature was maintained at 37°C with a circulating water blanket and was monitored together with the mice breathing during the experiment.
The T1 weighted gradient echo images were obtained with a dynamic contrast enhancement fast low angle shot (DCE-FLASH) sequence using the following parameters: TR/TE = 96.67/3 ms, FA = 15, FOV = 35×35 mm, MTX=128×128, temporal resolution = 10.247 s and cycle = 100. After the fifth scan, the commercial MRI contrast agent Gd-DTPA was intravenously administered over 2 s (0.17 mmol Gd kg -1 ) to monitor the perfusion of the contrast agent in 95 continued images. To calculate the proton density values, five T1-FLASH images were acquired before DCE-MRI sequences using the following parameters respectively: TR/TE=150/2.074 ms; FA=10, 15, 20, 25 and 30; FOV=35×35 mm; and MTX=128×128.
Six BALB/c mice were divided randomly into two groups: the Treatment group and the RF-control group (intravenous injection with saline and irradiation with RF). The experiments were conducted when the tumors reached a volume of 100 mm 3 5-7 days after tumor inoculation.
DCE-MRI data analysis
We reconstructed and analyzed the FLASH images with the MRICRON software. The dynamic FLASH data in DICOM format were processed using home-made programs in MATLAB. Regions of interest (ROIs) were manually drawn at the periphery of the middle tumor slice in each mouse for kinetic analysis because the tumor periphery is highly vascularized with angiogenic capillaries [38] . For the blood signal intensity (S) or arterial input function, ROIs were limited to the artery sections in normal tissue beside the tumor. The average signal intensity of the pre-contrast images (S 0 ) in the ROIs was used as the pretreatment value. The signal enhancement after contrast injection was calculated as follows:
where S t is the signal intensity at time t. The DCE-MRI data were converted into the concentration of the contrast agent using the different flip angle method [39] . The general equation for S values is as follows: The concentration of the contrast agent was calculated by the determination of the difference in the longitudinal relaxation rate, as follows:
The measured tissue concentration time course was individually fitted to the Tofts-Kety Model:
where K trans is the volume transfer constant between the blood plasma and extravascular extracellular space (EES) (min −1 ), υ p is the blood plasma volume per volume unit of tissue, C t is the tracer concentration in the tumor tissue and C p is the tracer concentration in the arterial blood plasma.
RESULTS AND DISCUSSION
Synthesis and characterizations of GFNCs
GFNCs were synthesized through a solid-liquid reaction by directly introducing the hydroxyl moieties onto solid Gd@C 82 with nucleophilic additions of H 2 O 2 . GFNCs were dialyzed against ultrapure water for 72 h and then verified by HPLC using a Cosmosil column, and the re-tention time was 4.3 min (Fig. 1a) . A peak with good symmetry appeared in the chromatograph, suggesting that the unreacted reagents were already removed and the as-prepared GFNCs were fully purified. As shown in Fig.  1b , the FTIR spectrum of GFNCs exhibits several peaks, in which the main peak at 3,400 cm −1 is assigned to the characteristic vibration bands of -OH and the middle peak at 1,598 cm −1 belongs to the skeletal vibration frequency of C=C of fullerenes. The peaks locating at 1,465-1,340 cm −1 are attributed to the asymmetric stretching bands of -C-OM (M=H, C), suggesting the existence of -C-OH and -C-O-C groups [40, 41] . The height and the diameter of GFNCs were approximately 30 nm and 80 nm as observed by AFM (Fig. 1c and Fig.  S1 ). The hydrodynamic size (approximately 157.2 nm) of GFNCs in aqueous solution measured by the dynamic light scattering (DLS) was obviously enlarged due to the coverage of the solvent layer (Fig. 1d) . GFNCs exhibited uniform distribution with a polydispersity index (PDI) of 0.202 and promoted stability with a highly negative zeta potential of −39.5 mV in ultrapure water.
Morphological and functional observation of the tumor vascular disruption by RF-assisted GFNCs treatment
The detail of the morphological and functional observation in tumor vasculature by RF-assisted GFNCs treatment was taken in a H22 tumor bearing DSFC model and combined with a RF coil. As shown in Fig. 2a , neovascularization was obviously visualized at 7 th day after tumor inoculation. A home-made 300 MHz RF coil was equipped on the back of DSFC for RF irradiation (Fig.  2b) .
First, the short-time observation of the tumor blood vessels was performed using vascular fluorescent perfusion imaging in the H22 tumor bearing DSFC model. The blood vessels of normal tissue in chamber treated by RFassisted GFNCs were studied as a control. FITC-dextran (70 kDa; 75 μL of 25 mg mL −1 ), a commonly used blood vessel marker, was intravenously pre-injected to label the vasculature. In the RF-assisted GFNCs treatment group, the tumor blood vessels were observed to gradually slow down with the reduced fluorescence perfusion within 15 min of treatment (Fig. 2c) . Instantly, the blood cells gradually aggregated and then the flow of the whole blood vessels sequentially shut off without perfusion of the FITC-dextran in treatment group from 15 to 60 min (Fig.  2c, highlighted by red arrows) . There was little influence on either tumor blood vessels in the RF alone group or normal blood vessels treated by RF-assisted GFNCs. In this study, it was significant that the RF-assisted GFNCs treatment leads to rapid blood flow shut off in tumor during treatment.
The typical destruction process of H22 tumor vascular morphology treated by RF-assisted GFNCs within 48 h was shown in Fig. 3a . The tumor vasculature in some areas (such as ROI. I, ROI. II and ROI. III highlighted by white dotted circles in Fig. 3b ) began to be broken and hemorrhaged during the treatment. With the time extending, the areas of hemorrhage of the tumor vasculature were continually increased in the three ROIs after treatment, leading to the remarkable collapse and fragmentation of the whole tumor vascular net. Within 24 h after treatment, the hemorrhagic damage and the decrease of the tumor blood vessels were continued. Vascular hemorrhage stopped and no recovery was observed at 48 h. Thus, the H22 tumor finally become necrotic by the rapid and persistent vascular collapse in morphology after the RF-assisted GFNCs treatment.
In addition, the structure of tumor vascular network could not be disrupted by RF treatment without administration of GFNCs. The tumor capillary blood vessels in ARTICLES . . . . . . . . . . . . . . . . . . . . . . . . . SCIENCE CHINA Materials   1106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . the RF-control group (Fig. S2 ) maintained good integrity under irradiation of 300 MHz RF for 1.5 h and minor change was found within 48 h after treatment. Moreover, it is obvious that the structure of normal vascular system was not disrupted under the RF assisted GFNCs treatment, which avoided damage to normal vessels to a large degree (Fig. S3) . Accordingly, the tissue pathological analysis in the previous report exhibited that the RF assisted GFNCs displayed negligible damage to the normal tissues, even to the liver tissue with higher accumulation of GFNCs [22] .
To further evaluate the long-term potential of RF assisted GFNCs to induce functional damage of the whole vascular net in H22 tumor xenografts, 2D-fluorescence perfusion imaging of the tumor vasculature was performed at the 4 th , 24 th and 48 th h post treatment. A standard macromolecular vessel marker, Rhodamine B isothiocyanate-dextran, was pre-injected intravenously into the mice to label the tumor vessels by perfusion and the frozen tumor sections were dissected from the mice for imaging. As shown in Fig. 3c , large degrees of reduction of perfused vessels were clearly observed due to the disruption of tumor vasculature in the treatment group. Compared with pre-treatment, the number of tumor blood vessels perfused was sequentially decreased at the 4 th and 24 th h with little change at the 48 th h posttreatment (Fig. 3c) . A remarkable drop in vascular perfusion was followed after treatment, indicating an obvious and permanent damage in function of the whole tumor vascular net.
In this study, it was significant that RF-assisted GFNCs could cause the rapid and specific hemorrhage and collapse of the partial tumor blood vessels due to the breakdown and abscission from the basilemma of endothelia cell in tumor vasculature (Fig. S4) [22] , efficiently leading to functional impairment of the whole tumor vascular net.
Quantification of disruption in tumor vascular function by RF-assisted GFNCs treatment using DCE-MRI in vivo
The DCE-MRI is a "gold standard" method to evaluate functional characteristics of the vascular net, giving out the information in the blood perfusion and the vascular permeability [42, 43] . Thus, we performed the quantitative DCE-MRI to assess tumor microvascular function after RF-assisted GFNCs treatment (Fig. 4a and b) . The H22 tumors (yellow dotted circles) were injected with Gd-DTPA and imaged with the DCE-FLASH sequence at different time points of treatment ( Fig. 4c and d) . Before the treatment, a rapid and great increase of the MRI signals after the Gd-DTPA injection was observed both in the RF-control group and RF-assisted GFNCs treatment group. While, in RF-assisted GFNCs treatment group, the increase of MRI signal intensity in the tumors was visibly lower compared with the RF-control group after Gd-DTPA injection (Fig. 4d) . Meanwhile, the concentration of the Gd-DTPA in the periphery of the H22 tumors before and after treatment at different time points was calculated for the RF-control and RF-assisted GFNCs treatment groups, and the representative concentrationtime curves were fitted in Fig. 4e and f. There was little change in the concentration of Gd-DTPA at different time points for the RF-control group. In the treatment group, slower and lower increase of the concentration of Gd-DTPA was observed with the decreased perfusion and no recovery until the 48 th h, indicating the functional damage of tumor blood vessels after RF-assisted GFNCs treatment.
After that, a pharmacokinetic parameter, K trans (the rate of transfer of the contrast agent from the blood to the interstitial space), was calculated from the DCE-MRI data using the classical Tofts-Kety model with homemade programs written in Matrix Laboratory (MATLAB). The value of K trans depends on the balance between capillary permeability and the blood flow in the tumor [44] . The ΔK trans values of the tumor boundary capillary at different treatment time points in two groups were shown in Fig. 5a . After RF-assisted GFNCs treatment, the values of K trans were dramatically decreased by 66.68%, 78.64% and 78.93% at the 4 th , 24 th and 48 th h post-treatment, respectively. In this study, the permeation of Gd-DTPA was significantly reduced and the concentration of Gd-DTPA displayed smaller and slower increments after treatment. As a result, the K trans values of H22 tumors were greatly and persistently reduced within 24 h after RF-assisted GFNC treatment and little change with no recovery at 48 h, suggesting considerable and permanent damage to the capillary function of the tumor. However, as for the RF-control group, the DCE-MRI parameters K trans of the whole tumor exhibited slight increase at the 4 th , 24 th and 48 th h post-treatment (increased by approximately 10.86%, 17.47% and 12.27%, respectively) because of neovascularization, suggesting that the RF did not disrupt the function of tumor vessels in mice without the administration of GFNCs. It was more visually displayed that the value of K trans in the whole tumor was markedly decreased after RF-assisted GFNCs treatment compared to the RF control group in K trans mapping (Fig. 5b) . As a result, the supply of oxygen and nutrients for tumor was eventually cut off in the whole tumor vascular network after RF-assisted GFNCs treatment due to the outstanding vascular disrupting effects, leading to an accelerated ischemic necrosis of tumor.
CONCLUSIONS
In summary, we first displayed the real-time process of the tumor vascular disruption by RF-assisted GFNCs treatment qualitatively and quantitatively. The rapid and selective disintegration in morphology of local tumor vasculature had been real-time observed in the DSFC model, followed by a persistent and extensive destruction in function of the whole corresponding tumor vasculature which was quantified with the DCE-MRI. After the RFassisted GFNCs treatment, several tumor blood vessels were shut off and ruptured, leading to the collapse of whole tumor vascular network, which finally caused the tumor ischemic necrosis. These results indicate a clear mechanism of RF-assisted GFNCs treatment based on tumor vascular disruption, which is beneficial for the clinical application of this technique in the future. 
